56
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Prevalence of leptospira in acute hepatitis syndrome and assessment of IL-8 and TNF-alpha level in leptospiral hepatitis

, , , &
Pages 499-506 | Received 08 Mar 2011, Accepted 06 Sep 2011, Published online: 24 Feb 2014
 

Abstract

To study the prevalence of leptospira in acute hepatitis syndrome and to assess interleukin (IL)-8 and tumour necrosis factor (TNF)-alpha levels in the pathogenesis of hepatitis due to leptospiral infection.

Two hundred and forty-seven consecutive cases with symptoms of acute hepatitis and 30 healthy controls were enrolled in the study and detailed clinical history was elicited from them. Enzyme-linked immunosorbent assays (ELISAs) for HAV, HBV, HCV and HEV were performed to rule out common viral aetiology of hepatitis. IgM antibodies to leptospira were detected by ELISA. IL-8 and TNF-alpha levels were estimated in leptospira-positive cases and healthy controls by ELISA.

Out of 247 cases of acute hepatitis, 46 (18·62%) were observed to be positive for IgM antibodies for leptospira. The mean age of these patients was 31·99±0·28 years (25 males and 21 females; M/F ratio: 1·19∶1). The mean ALT, AST and ASP were raised in the majority of patients. IL-8 was found to be elevated (130·81 pg/ml) in a large majority of cases 41/46, 89·1% (P<0·001). Patients with more severe symptoms were associated with higher levels of IL-8. One mortality was observed due to leptospira. Unpredictably, TNF-alpha level was largely suppressed (45·63 pg/ml) in most of the leptospira-positive patients in comparison with healthy controls.

Leptospira-induced hepatitis should be actively looked for in patients negative for A–E viral hepatitis. IL-8 appears to play an important role in the pathogenesis of leptospiral hepatitis. High TNF-alpha should alert clinicians for aggressive in hospital management of patients.

This work was supported by grants from Department of Science and Technology (DST), Ministry of Science and Technology, INDIA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.